http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105907851-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 |
| filingDate | 2016-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105907851-B |
| titleOfInvention | Purposes of the site rs77191406 in the kit of the preparation prediction secondary malignant tumour of RA and SLE |
| abstract | The invention discloses purposes of the site rs77191406 in the kit of the preparation prediction secondary malignant tumour of RA and SLE.Inventor has found that A20 gene SNP rs77191406 is related to RA and SLE occurrence of malignant tumors for the first time, and rs77191406 can be used as the prediction index of the secondary malignant tumour of RA and SLE.It thus provides the site rs77191406 is in the purposes prepared in the kit for predicting the secondary malignant tumour of RA and SLE and provides a kind of kit for predicting the secondary malignant tumour of RA and SLE.Rs77191406 of the invention has important meaning to the prediction secondary malignant tumour of RA and SLE, there is very big clinical value and good application prospect. |
| priorityDate | 2016-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 15.